دورية أكاديمية
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts
| العنوان: | The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts |
|---|---|
| المؤلفون: | Behrens, Diana, Lykkesfeldt, Anne E., Fichtner, Iduna |
| المصدر: | Targeted Oncology. July 2007 2(3):135-144 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 17762596 1776260X |
|---|---|
| DOI: | 10.1007/s11523-007-0054-5 |